AgeX Therapeutics Inc (DELISTED) (AGE:DL)
11.10
-1.50
(-11.90%)
USD |
NYAM |
Mar 26, 16:00
12.18
+1.08
(+9.73%)
After-Hours: 20:00
AgeX Therapeutics Free Cash Flow: -7.069M for Sept. 30, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2023 | -7.069M |
| June 30, 2023 | -6.441M |
| March 31, 2023 | -6.168M |
| December 31, 2022 | -5.939M |
| September 30, 2022 | -6.265M |
| June 30, 2022 | -6.913M |
| March 31, 2022 | -6.861M |
| December 31, 2021 | -7.855M |
| September 30, 2021 | -7.828M |
| June 30, 2021 | -7.833M |
| Date | Value |
|---|---|
| March 31, 2021 | -8.383M |
| December 31, 2020 | -7.837M |
| September 30, 2020 | -8.923M |
| June 30, 2020 | -9.631M |
| March 31, 2020 | -10.25M |
| December 31, 2019 | -10.80M |
| September 30, 2019 | -10.14M |
| June 30, 2019 | -10.40M |
| March 31, 2019 | -9.703M |
| December 31, 2018 | -9.888M |
Free Cash Flow Range, Past 5 Years
-10.80M
Minimum
Dec 2019
-5.939M
Maximum
Dec 2022
-8.085M
Average
-7.835M
Median
Free Cash Flow Benchmarks
| Homology Medicines Inc (DELISTED) | -96.46M |
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
| iBio Inc | -18.67M |
| Theriva Biologics Inc | -18.27M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.864M |
| Cash from Financing (Quarterly) | 2.00M |
| Free Cash Flow Per Share (Quarterly) | -1.727 |
| Free Cash Flow to Equity (Quarterly) | 28.93M |
| Free Cash Flow Yield | -59.02% |